C260H276F24N52O16 — CID 165080670
3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrimidin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;N-[6-[5-[2-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-2-oxoethyl]-2-methylphenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide (PubChem CID 165080670) has the molecular formula C260H276F24N52O16 and a molecular weight of 4841.37 g/mol. Its IUPAC name is 3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrimidin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;N-[6-[5-[2-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-2-oxoethyl]-2-methylphenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide.
| Compound Name | 3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrimidin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;N-[6-[5-[2-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-2-oxoethyl]-2-methylphenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide |
|---|---|
| PubChem CID | 165080670 |
| Molecular Formula | C260H276F24N52O16 |
| Molecular Weight | 4841.37 g/mol |
| Exact Mass | 4838.20 |
| IUPAC Name | 3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyridin-6-yl]-N-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-a]pyrimidin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;3-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-7-yl]-N-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-4-methylbenzamide;N-[6-[5-[2-[3-[(4-ethylpiperazin-1-yl)methyl]-5-(trifluoromethyl)phenyl]-2-oxoethyl]-2-methylphenyl]imidazo[1,2-a]pyridin-2-yl]cyclopropanecarboxamide |
| SMILES | CCN1CCN(Cc2cc(C(=O)Cc3ccc(C)c(-c4ccc5nc(NC(=O)C6CC6)cn5c4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5nc(NC(=O)C6CC6)cn5c4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5nc(NC(=O)C6CC6)cn5n4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccc5nc(NC(=O)C6CC6)nn5c4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4ccn5nc(NC(=O)C6CC6)nc5c4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4cn5cc(NC(=O)C6CC6)nc5cn4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2cc(NC(=O)c3ccc(C)c(-c4cnc5nc(NC(=O)C6CC6)cn5c4)c3)cc(C(F)(F)F)c2)CC1.CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(-c4ccc5nc(NC(=O)C6CC6)cn5c4)c3)cc2C(F)(F)F)CC1 |
| InChI | InChI=1S/C34H36F3N5O2.2C33H35F3N6O2.5C32H34F3N7O2/c1-3-40-10-12-41(13-11-40)19-24-14-27(18-28(15-24)34(35,36)37)30(43)17-23-5-4-22(2)29(16-23)26-8-9-32-38-31(21-42(32)20-26)39-33(44)25-6-7-25;1-3-40-12-14-41(15-13-40)18-25-8-10-26(17-28(25)33(34,35)36)37-32(44)23-5-4-21(2)27(16-23)24-9-11-30-38-29(20-42(30)19-24)39-31(43)22-6-7-22;1-3-40-10-12-41(13-11-40)18-22-14-26(33(34,35)36)17-27(15-22)37-32(44)24-5-4-21(2)28(16-24)25-8-9-30-38-29(20-42(30)19-25)39-31(43)23-6-7-23;1-3-40-8-10-41(11-9-40)17-21-12-25(32(33,34)35)15-26(13-21)37-30(44)23-5-4-20(2)27(14-23)24-16-36-31-39-28(19-42(31)18-24)38-29(43)22-6-7-22;1-3-40-8-10-41(11-9-40)17-21-12-24(32(33,34)35)15-25(13-21)37-31(44)23-5-4-20(2)26(14-23)27-18-42-19-28(38-29(42)16-36-27)39-30(43)22-6-7-22;1-3-40-10-12-41(13-11-40)19-21-14-25(32(33,34)35)18-26(15-21)36-30(44)24-5-4-20(2)27(16-24)23-8-9-42-28(17-23)37-31(39-42)38-29(43)22-6-7-22;1-3-40-10-12-41(13-11-40)18-21-14-24(32(33,34)35)17-25(15-21)36-31(44)23-5-4-20(2)26(16-23)27-8-9-29-37-28(19-42(29)39-27)38-30(43)22-6-7-22;1-3-40-10-12-41(13-11-40)18-21-14-25(32(33,34)35)17-26(15-21)36-30(44)23-5-4-20(2)27(16-23)24-8-9-28-37-31(39-42(28)19-24)38-29(43)22-6-7-22/h4-5,8-9,14-16,18,20-21,25H,3,6-7,10-13,17,19H2,1-2H3,(H,39,44);4-5,8-11,16-17,19-20,22H,3,6-7,12-15,18H2,1-2H3,(H,37,44)(H,39,43);4-5,8-9,14-17,19-20,23H,3,6-7,10-13,18H2,1-2H3,(H,37,44)(H,39,43);4-5,12-16,18-19,22H,3,6-11,17H2,1-2H3,(H,37,44)(H,38,43);4-5,12-16,18-19,22H,3,6-11,17H2,1-2H3,(H,37,44)(H,39,43);4-5,8-9,14-18,22H,3,6-7,10-13,19H2,1-2H3,(H,36,44)(H,38,39,43);4-5,8-9,14-17,19,22H,3,6-7,10-13,18H2,1-2H3,(H,36,44)(H,38,43);4-5,8-9,14-17,19,22H,3,6-7,10-13,18H2,1-2H3,(H,36,44)(H,38,39,43) |
| InChIKey | VBCBTHIYEVRTQW-UHFFFAOYSA-N |
| XLogP | 45.68 |
| TPSA | 708.26 Ų |
| H-Bond Donors | 15 |
| H-Bond Acceptors | 53 |
| Rotatable Bonds | 65 |
| Heavy Atoms | 352 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4841.37 |
| LogP ≤ 5 | 45.68 |
| H-Bond Donors ≤ 5 | 15 |
| H-Bond Acceptors ≤ 10 | 53 |